medigraphic.com
Instituto Nacional de Salud Pública

2016, Number 2

<< Back Next >>

salud publica mex 2016; 58 (2)

Integrated oncology and palliative care: five years experience at the National Cancer Institute of Mexico

Allende-Pérez S, Verástegui-Avilés E, Mohar-Betancourt A, Meneses-García A, Herrera-Gómez A

Language: English
References: 54
Page: 317-324
PDF size: 231.30 Kb.


ABSTRACT

Under the national plan for addressing cancer, prevention and detection play important roles. However, the cost of treatments and late diagnosis represent a significant burden on health services. At the National Cancer Institute, more than half of patients present with tumors in advanced stages, and approximately 10% of patients seen for the first time exhibit terminal-stage malignancies, where there are no feasible cancer treatment options, and the patients are instead admitted to the hospital exclusively for palliative symptomatic management. In 2010, the National Cancer Plan began implementing a model of integrative management of palliative care in oncology that has gradually come to include symptomatic palliative care, involving ambulatory, distant and hospitalized management of patients with cancer, in its final stages and, more recently, in earlier stages.


REFERENCES

  1. GBD 2013 Mortality and Causes of Death Collaborators Global, regional and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015; 385(9963):117-171. DOI: http://dx.doi.org/10.1016/S0140-6736(14)61682-2

  2. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380(9859):2095-2128. doi: 10.1016/S0140- 6736(12)61728-0.

  3. Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet 1997;349(9061):1269-1276.

  4. Global Burden of Disease Cancer Collaboration, Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M, MacIntyre MF, et al. The Global Burden of Cancer 2013. JAMA Oncol 2015;4:505-27. doi: 10.1001/jamaoncol. 2015.0735.

  5. Allemani C, Weir HK, Carreira H, Harewood R, Spika D, Wang XS, et al. Global surveillance of cancer survival 1995-2009: analysis of individual data for 25,676,887 patients from 279 population-based registries in 67 countries (CONCORD-2). Lancet 2015;385(9972):977-1010. doi: 10.1016/S0140-6736(14)62038-9.

  6. Edwards BK, Noone AM, Mariotto AB, Simard EP, Boscoe FP, Henley SJ. Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer 2014;120(9):1290-314. doi: 10.1002/cncr.28509.

  7. Coleman MP, Gatta G, Verdecchia A, Estève J, Sant M, Storm H. EUROCARE- 3 summary: cancer survival in Europe at the end of the 20th century. Ann Oncol 2003;14 Suppl 5:v128-49.

  8. Frankish H. 15 million new cancer cases per year by 2020, says WHO. Lancet 2003;361(9365):1278

  9. The World Bank Group [Internet]. Mexico Data [accessed on December 12, 2015]. Available at http://data.worldbank.org/country/mexico.

  10. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer. 2013 [accessed on December 8, 2015]. Available at: http://globocan.iarc.fr/old/burden.asp?selection_pop=126484&Textp= Mexico&selection_cancer=290&Text-c=All+cancers+excl.+non-melan oma+skin+cancer&pYear=3&type=0&window=1&submit=%C2%A0Exec ute%C2%A0,

  11. Schnipper LE, Smith TJ, Raghavan D, Blayney DW, Ganz PA, Mulvey TM, et al. American Society of Clinical Oncology identifies five key opportunities to improve care and reduce costs: the top five list for oncology. J Clin Oncol 2012;30(14):1715-24. doi: 10.1200/JCO.2012.42.8375.

  12. Allende-Pérez S, Herrera A, Meneses A, Mohar A, De La Garza J, Verástegui E. Care for All: Palliative Care Strategy to Provide Intensive Acute Symptom Control Management for Patients with Previously Undiagnosed Terminal Cancer. J Palliat Care Med 2014;4(5):1-5 [accessed on December 8, 2015]. Available from: http://www.omicsgroup.org/journals/ care-for-all-palliative-care-strategy-to-provide-intensive-acute-symptomcontrol- management-for-patients-with-previously-undiagnosed-terminalcancer- 2165-7386.1000188.pdf, accessed on 8/12/2015.

  13. Goss PE, Lee BL, Badovinac-Crnjevic T, Strasser-Weippl K, Chavarri- Guerra Y, St Louis J, et al. Planning cancer control in Latin America and the Caribbean. Lancet Oncol 2013;14(5):391-436. doi: 10.1016/S1470- 2045(13)70048-2.

  14. Connor SR, Sepulveda-Bermedo MC. Global Atlas of Palliative Care at the End of Life. Worldwide Palliative Care Alliance, World Health Organization, 2014 [accessed on December 9, 2015]. Available from: http://www. who.int/nmh/Global_Atlas_of_Palliative_Care.pdf,

  15. 67.ª Asamblea Mundial de la Salud. Resoluciones y decisiones. Resolución WHA67.19 Fortalecimiento de los Cuidados Paliativos como parte del tratamiento integral a lo largo de la vida. pp. 38. Ginebra, 2014 [accessed on December 8, 2012]. Available from: http://apps.who.int/gb/ ebwha/pdf_files/WHA67-REC1/A67_2014_REC1-sp.pdf ,

  16. Word Health Organization. WHO Definition of Palliative Care [accessed on December 7, 2015]. Available at: http://www.who.int/cancer/ palliative/definition/en/, accessed on 7/12/2015

  17. Foley KM. The treatment of cancer pain. N Engl J Med 1984;313(2):84-95.

  18. Caraceni A, Portenoy RK. An international survey of cancer pain characteristics and syndromes. IASP Task Force on Cancer Pain. International Association for the Study of Pain. Pain 1999; 82(3):263-274.

  19. Cancer pain relief and palliative care; report of a WHO expert Committee Geneva, World Health Organization, 1990 (WHO Technical Report Series, No 804) [accessed on December 10, 2015]. Available from: http:// apps.who.int/iris/bitstream/10665/39524/1/WHO_TRS_804.pdf,

  20. Romero J, Plancarte A, Guerrero G, Amezcua C, Liceaga M, Allende S. Prevalencia del dolor por cáncer en una población de pacientes de nuevo ingreso en el Instituto Nacional de Cancerología. J Pain Symptom Manage 1988;3:571-577

  21. Plancarte R, Amescua C, Patt RB, Aldrete JA. Superior hypogastric plexus block for pelvic cancer pain. Anesthesiology 1990;73:236-239.

  22. Allende S, Carvell H. Mexico: Status of cancer pain and palliative care. J Pain Symptom Manage 1996;12:121-126

  23. García-Olivera V. La clínica del dolor; su origen y evolución. Rev Mex Anest. 2002;25:15-18 [accessed on December 10, 2015]. Available at: http://www.medigraphic.com/pdfs/rma/cma-2002/cma021c.pdf,

  24. Covarrubias-Gómez A, Guevara-Lopez U. ¿Qué son las clínicas del dolor? Revista Digital Universitaria 2006;7:3-7 [accessed on December 7, 2015]. Available from: http://www.revista.unam.mx/vol.7/num4/art33/ abr_art33.pdf,

  25. Caraceni A, Martini C, Zecca E, Portenoy RK, Ashby MA, Hawson G, et al. Working Group of an IASP Task Force on Cancer Pain. Breakthrough pain characteristics and syndromes in patients with cancer pain. An International survey. Palliat Med 2004;18:177-183.

  26. Task Force for Cancer Pain Management, Guevara-López U, Covarrubias- Gómez A, Ochoa-Carillo FJ, Fernández-Orozco F, Bernal-Sahagún F. Practice guidelines for cancer pain management. Task Force for Cancer Pain Management. Cir Ciruj 2006;74(5):381-396.

  27. Silva JH. Manejo integral del dolor por cáncer. En: Bistre S, Araujo M. Dolor: síntoma, síndrome y padecimiento. México: Azerta Comunicación Creativa, 2003:153-158.

  28. Reyes-Chiquete D, González-Ortiz A, Mohar-Betancourt A, Meneses- García A. Epidemiología del dolor por cáncer. Rev Soc Esp Dolor 2011;2:118-134 [accessed on December 10, 2015]. Available at: http:// scielo.isciii.es/pdf/dolor/v18n2/revision1.pdf,

  29. Plancarte SR, Guajardo RJ, Guillen NR. Manejo integral del dolor. Cancerología 2006;1:273-281 [accessed on December 10, 2015]. Available from: http://www.incan.org.mx/revistaincan/elementos/documentosPortada/ 1172291012.pdf,

  30. Lara-Solares A. Introducción a los cuidados paliativos. Revista Mexicana de Anestesiología 2005;28(1):S193-S195 [accessed on December 10, 2015]. Available from: http://www.medigraphic.com/pdfs/rma/cma-2005/ cmas051az.pdf,

  31. Montejo-Rosas G, Galaviz-Muro A, Espinoza-Rodríguez LN, Cortéz- Gutiérrez L. Cuidados paliativos en cáncer avanzado. Experiencia de siete años en el hospital civil de Guadalajara, Jalisco, México, Dr. Juan I. Menchaca. Gac Med Mex 2002;138(3):231-234 [accessed on December 9, 2015]. Available at: http://www.anmm.org.mx/bgmm/1864_2007/2002-138- 3-231-234.pdf,

  32. Montejo-Rosas G. El enfermo con cáncer incurable en México y la medicina paliativa. Salud Pública Mex 1992;34:569-574 [accessed on December 11, 2015]. Available from: http://bvs.insp.mx/rsp/_files/ File/1992/199234_569-574.pdf,

  33. Pastrana T, De Lima L, Wenk R, Eisenchlas J, Monti C, Rocafort J, Centeno C. Atlas de Cuidados Paliativos de Latinoamérica ALCP. Houston: IAHPC Press, 2012 [accessed on December 12, 2015]. Available from: http://cuidadospaliativos.org/atlas-de-cp-de-latinoamerica/,

  34. Human Rights Watch. (2014) Care When There Is No Cure [accessed on December 12, 2015]. Available from: https://www.hrw.org/ report/2014/10/28/care-when-there-no-cure/ensuring-right-palliativecare- mexico,

  35. Lynch T, Connor S. Clark D. Mapping levels of palliative care development: a global update 2013;45:1094-1105 [accessed on December 12, 2015]. Available at: http://dx.doi.org/10.1016/j.jpainsymman.2012.05.011.

  36. Pástrana T, Torres-Vigil I, De Lima L. Palliative care development in Latin America: an analysis using macro indicators. Palliative Medicine 2014;28(10):1231-1238 doi: 10.1177/0269216314538893.

  37. Decreto por el que se reforma y adiciona la Ley General de Salud en Materia de Cuidados Paliativos. Secretaría de Gobernación. México: Diario Oficial de la Federación [accessed on: December 10, 2015]. Available from: http://dof.gob.mx/nota_detalle.php?codigo=5076793&fec ha=05/01/2009,

  38. Modificaciones al Reglamento de la Ley General de Salud en Materia de Prestación de servicios de atención médica. Adición del Capítulo VIII BIS Disposiciones para la Prestación de Servicios de Cuidados Paliativos. Secretaría de Gobernación. México: Diario Oficial de la Federación. D.O.F 11-01-2013 [accessed on December 9, 2015]. Available at: http://www. diputados.gob.mx/LeyesBiblio/regley/Reg_LGS_MPSAM.pdf,

  39. Norma Oficial Mexicana NOM-011-SSA3-2014. Criterios para la atención de enfermos en situación terminal a través de cuidados paliativos. Secretaría de Gobernación. México: Diario Oficial de la Federación, 12/09/2014 [accessed on December 6, 2015]. Available from: http://dof. gob.mx/nota_detalle.php?codigo=5375019&fecha=09/12/2014,

  40. Acuerdo por el que el Consejo de Salubridad General Declara la Obligatoriedad de los Esquemas de Manejo integral de Cuidados Paliativos, así como los procesos señalados en la Guía del Manejo Integral de Cuidados Paliativos. México: Diario Oficial de la Federación, 12/26/2014 [accessed on December 6, 2015]. Available from: http://www.dof.gob.mx/nota_detalle. php?codigo=5377407&fecha=26/12/2014,

  41. Plancarte-Sanchez R, Guajardo-Rosas J, Cerezo-Camacho O, Chejne- Gomez F, Gomez-Garcia F, Meneses-Garcia A, et al. Femoroplasty: a new option for femur metastasis. Pain Pract 2013;13(5):409-15. doi: 10.1111/ j.1533-2500.2012.00590.

  42. Le Galès-Camus C, Resnikoff S, Sepúlveda C. Cuidados paliativos. Control del cáncer: aplicación de los conocimientos; guía de la OMS para desarrollar programas eficaces; módulo 5. Ginebra, Suiza: Organización Mundial de la Salud, 2007 [accessed on December 11, 2015]. Available from: http:// apps.who.int/iris/bitstream/10665/44025/1/9789243547343_spa.pdf,

  43. Allende-Pérez S, Verástegui-Avilés E, Mohar-Betancourt A, Arrieta- Rodríguez O, Barrera-Franco JL, Castañeda-de la Lanza C. Incorporación de los cuidados paliativos al Plan Nacional de Cáncer: consenso. Gaceta Mexicana de Oncología 2013;12(4):213-222.

  44. Allende-Pérez S, Ortega-Olvera L, Verástegui-Avilés E, Domínguez- Ocadio G, Monreal-Carrillo E, Ascencio-Huerta L. La pieza perdida en la medicina actual: atención domiciliaria a pacientes paliativos oncológicos. Gaceta Mexicana de Oncología 2013;12:229-233.

  45. Domínguez-Ocadio G, Allende-Pérez S, Verástegui-Avilés E, Monreal- Carrillo E. Medicina del futuro: atención virtual como modelo de atención en Medicina Paliativa Gaceta Mexicana de Oncología 2013;12:240-243.

  46. Allende-Pérez S, Verástegui-Avilés E, Chavira-Estefan S, Tejeida-Bautista L, Domínguez-Ocadio G ¿Cuándo referir a un paciente con cáncer a cuidados paliativos? Gaceta Mexicana de Oncología 2013;2:280-285.

  47. Hui D, Finlay E, Buss M, Prommer E, Bruera E. Palliative Oncologists: Specialists in the Science and Art of Patient Care. J Clin Oncol 2015;33:2314-2318 doi: 10.1200/JCO.2014.60.

  48. Cherny N, Catane R, Schrijvers D, Kloke M, Strasser F. European Society for Medical Oncology (ESMO) Program for the integration of oncology and Palliative Care: a 5-year review of the Designated Centers’ incentive program. Ann Oncol 2010;21(2):362-369. doi: 10.1093/annonc/mdp318.

  49. European Society for Medical Oncology, ESMO 2015 [Internet]. Designated Centres of Integrated Oncology and Palliative Care. World Health Organization 2013 [accessed on December 7, 2015]. Available at: http:// www.esmo.org/Patients/2015-ESMO-Designated-Centres,

  50. Smith TJ, Temin S, Alesi ER, Abernethy AP, Balboni TA, Basch EM, et al. American Society of Clinical Oncology provisional clinical opinion: the integration of palliative care into standard oncology care. J Clin Oncol 2012;30(8):880-7. doi: 10.1200/JCO.2011.38.5161

  51. Global action plan for the prevention and control of noncommunicable diseases 2013-2020. Who Library Cataloguing-In-Publication Data. Geneva: World Health Organization, 2013 [accessed December 12, 2015]. Available from: http://apps.who.int/iris/bitstre am/10665/94384/1/9789241506236_eng.pdf?ua=1,

  52. Escutia-Gutiérrez R. Guía práctica del Uso Racional de Analgésicos Opioides. México: Tecnofarma, 2011 [accessed on December 5, 2015]. Available for: http://www.palia.gob.mx/site/images/recursos_electronicos/ Guia_practica_Racional_de_Analgesicos_Opioides_Raymundo_Escutia_ 2011.pdf.

  53. Allende S, Verástegui E, Jesus F, Talavera. Myths in Cancer Patients about the Use of Morphine in a Third Level Hospital. Instituto Nacional de Cancerología, Cuidados Paliativos, Distrito Federal, Mexico European Journal of Palliative Care 14th World Congress of the European Association for Palliative Care (EAPC) Copenhagen, Denmark, 10 May 2015. Abstract Book. P2-002:173 [accessed on December 4, 2015]. Available from: http:// www.eapc-2015.org/tl_files/eapc15/Downloads/EAPC_2015_Abstract_ Book.pdf,

  54. Murray S. The 2015 Quality of Death Index. Ranking palliative care across the world. A report by The Economist Intelligence Unit. Line D, ed [accessed on December 8, 2015]. Available from: http://www.economistinsights. com/healthcare/analysis/quality-death-index-2015/%20world.




2020     |     www.medigraphic.com